|Articles|February 1, 2016
- Pharmaceutical Executive-02-01-2016
- Volume 36
- Issue 2
Pharmaceutical Executive, February 2016 Issue (PDF)
Click the title above to open the Pharmaceutical Executive February 2016 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 9 years ago
Life and Lipitor: Pfizer's Traci Medford-Rosowover 9 years ago
The Staying Power of Emerging Marketsalmost 10 years ago
Canada's Rx&D: Fresh Start for a New Eraalmost 10 years ago
Morgan Moments: A Closer Reading of the JP Morgan Investor Conferencealmost 10 years ago
Pharma dot-gov: A New Business Modelalmost 10 years ago
The Creative Impulse: Defending Pharma and Health DTCalmost 10 years ago
Securing Cipla’s Futurealmost 10 years ago
Country Report: South AfricaNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Novo Nordisk Sends Amended Acquisition Proposal to Metsera
2
Pharmaceutical Executive Daily: Kimberly-Clark’s $48.7 Billion Acquisition of Kenvue
3
FDA Approves Kygevvi Becoming the First Treatment for Thymidine Kinase 2 Deficiency
4
Texas Files to Prevent Kenvue Dividend Payment
5
